News

Genmab A/S Completes Successful Share Buy-back Program

Genmab A/S Completes Successful Share Buy-back Program

Genmab A/S Completes Successful Share Buy-back Program

Company Announcement

Genmab A/S (NASDAQ: GMAB) has proudly announced the successful completion of its share buy-back program, which came to a close on June 26, 2025. Initially launched in March, the program aimed to repurchase up to 2.2 million shares as part of a strategic initiative to reduce the company's capital while honoring commitments under the Restricted Stock Unit program.

Despite an initial estimate for the program's completion by July, activities continued efficiently, and shareholders were informed of varying transactions that took place between June 23, 2025, and June 26, 2025.

Detailed Transactions Under the Share Buy-back Program

Throughout the program, Genmab reported a total of 118,789 shares acquired, amounting to a value exceeding 157 million DKK. Each transaction showcased the commitment of Genmab to strengthen shareholder equity. The transactions were executed across various trading platforms, including XCSE, BCXE, AQEU, and TQEX, with comprehensive transaction details outlined in the public announcement.

The buy-backs were distributed as follows:

  • On June 23, 2025, a total of 100 shares were purchased on the XCSE platform.
  • On June 24, the company executed total share transactions of 26,129 shares.
  • June 25 saw 45,961 shares acquired across multiple platforms.
  • Finally, on June 26, 46,599 shares were bought back to conclude the program.

As a result of these transactions, Genmab retained about 2,651,727 shares as treasury shares, constituting 4.13% of the overall share capital and voting rights. This demonstrates Genmab's robust response to optimizing capital distribution and enhancing long-term value for its shareholders.

Compliance with Regulations

The share buy-back program was conducted under strict adherence to Regulation (EU) No. 596/2014, also known as the Market Abuse Regulation (MAR), along with the Commission Delegated Regulation (EU) 2016/1052 recognized as the Safe Harbour Regulation. This regulatory framework ensures transparency and fairness in share repurchase activities, providing reassurance to both investors and stakeholders.

For those interested in further details, they are available in Genmab's announcement dated March 25, 2025, outlining the parameters and objectives of the share buy-back program in a comprehensive format.

Genmab's Vision and Commitment to Innovation

Genmab is driven by a relentless commitment to innovation and improvement in patient care through biotechnology. Its focus lies in developing differentiated antibody therapeutics aimed at treating some of the most challenging diseases, particularly cancer.

With a legacy spanning over 25 years, Genmab's dedicated team has been at the forefront of ingenuity, creating next-generation antibody platforms and utilizing advanced quantitative and data sciences. The company envisions transforming patient lives through innovative therapeutic solutions, as seen in its proprietary pipeline featuring bispecific T-cell engagers and next-generation immune checkpoint modulators.

Looking forward to 2030, Genmab aims to deliver remarkable antibody medicines that can alter the course of treatment for patients, further solidifying its status as a pioneering company in the biotechnology landscape.

Contact Information for Further Inquiries

For more insights or inquiries regarding the share buy-back program or Genmab’s innovative initiatives, individuals can reach out to:

Contact:

Marisol Peron, Senior Vice President, Global Communications & Corporate Affairs
T: +1 609 524 0065; E: mmp@genmab.com

Andrew Carlsen, Vice President, Head of Investor Relations
T: +45 3377 9558; E: acn@genmab.com

Frequently Asked Questions

What was the purpose of Genmab's share buy-back program?

The program aimed to repurchase shares to reduce capital and honor commitments under the Restricted Stock Unit program.

How many shares were repurchased by Genmab?

A total of 118,789 shares were repurchased under the program.

What is Genmab's core focus as a biotechnology company?

Genmab focuses on developing innovative antibody therapeutics, particularly in the field of oncology.

Which regulatory frameworks guided the share buy-back program?

The program was conducted in line with Regulation (EU) No. 596/2014 and Commission Delegated Regulation (EU) 2016/1052.

How can I get more information about Genmab?

For further inquiries, you can contact Genmab's communications and investor relations teams via listed email addresses.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 3

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
Trust vs. AI: Shapira's Fight in Modern Speechcraft

Updated Category News Views 5

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Continue Reading
Piedmont Orthopedics Expands Care in Henry County

Updated Category News Views 12

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 7

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 6

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 6

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 6

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Bud Ecosystem Debuts AIOS, Aims to Slash Costs

Updated Category News Views 7

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Continue Reading

Top 5 Most Recently Viewed Articles

Highlights from Tivoli A/S Annual General Meeting Decisions

Updated Category News Views 135

Key Outcomes of Tivoli A/S Annual General Meeting Tivoli A/S held its Annual General Meeting recently, where significant decisions were made regarding the company's future. One of the primary announcements made was the approval of the annual report, which included a proposal from the Board of Directors to distribute a dividend. This distribution is set at 25% of the...

Continue Reading
California's Innovative AI Curriculum: Preparing Future Leaders

Updated Category News Views 284

California's Bold AI Initiative in Education As technology rapidly evolves, the importance of AI in our daily lives and workplaces cannot be overstated. California has taken a significant step in ensuring that students are equipped for the future by partnering with major tech firms such as Alphabet Inc., Adobe Inc., International Business Machines Corp., and Microsoft...

Continue Reading
FactSet's Strong Q4 Performance: Growth and Future Outlook

Updated Category News Views 177

FactSet Reports Fourth Quarter 2025 Results FactSet, a leading player in the financial services sector, has revealed its financial performance for the fourth quarter of fiscal 2025. The company reported a significant increase in GAAP revenues, amounting to $596.9 million, which marks a 6.2% rise compared to the same quarter in the previous year. For the entire fiscal...

Continue Reading
APT Miner Unveils GreenMine 2.0: A Leap Towards Sustainable Mining

Updated Category News Views 262

APT Miner Introduces GreenMine 2.0: A Revolutionary Change Cloud mining is witnessing a tremendous surge in popularity, driven by innovative platforms like APT Miner. As the cryptocurrency market evolves, APT Miner is effectively aligning itself with market trends and user demands, especially with the impressive growth of Bitcoin, which recently surpassed the $109,000...

Continue Reading
Smackover Lithium Achieves Positive Milestone with DFS Results

Updated Category News Views 188

Smackover Lithium Presents Positive Definitive Feasibility Study Findings Smackover Lithium has successfully completed a thorough Definitive Feasibility Study (DFS) for its promising lithium extraction initiative. This significant endeavor, a collaboration between Standard Lithium Ltd. (NASDAQ: SLI) and the energy company Equinor, underscores the potential of their South...

Continue Reading